Fertility and Sterility
Volume 94, Issue 6 , Pages 2161-2166 , November 2010

Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial

  • Shrita M. Patel, M.D., M.S.C.E.

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Nayyar Iqbal, M.D., M.S.C.E.

      Affiliations

    • Section of Endocrinology, Diabetes, and Metabolism, Philadelphia VA Medical Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Shailja Kaul, M.B.B.S.

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Sarah J. Ratcliffe, Ph.D.

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Michael R. Rickels, M.D., M.S.

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Muredach P. Reilly, M.B., M.S.C.E.

      Affiliations

    • Cardiovascular Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Theresa Scattergood, R.N., M.S.N.

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Arpita Basu, M.B.B.S.

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Carissa Fuller, C.R.N.P.

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Anne R. Cappola, M.D., Sc.M.

      Affiliations

    • Division of Endocrinology, Diabetes, and Metabolism, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Corresponding Author InformationReprint requests: Anne R. Cappola, M.D., Sc.M., University of Pennsylvania School of Medicine, 764 CRB, 415 Curie Blvd., Philadelphia, PA 19104 (FAX: (215) 898-5408).

Received 11 November 2009 ,Revised 20 January 2010 ,Accepted 25 January 2010.

References 

  1. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med. 1996;335:617–623
  2. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab. 2000;85:139–146
  3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002;287:356–359
  4. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics—2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2009;119:480–486
  5. Cappola AR, Ratcliffe SJ, Bhasin S, Blackman MR, Cauley J, Robbins J, et al. Determinants of serum total and free testosterone levels in women over the age of 65 years. J Clin Endocrinol Metab. 2007;92:509–516
  6. Patel SM, Ratcliffe SJ, Reilly MP, Weinstein R, Bhasin S, Blackman MR, et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2009;94:4776–4784
  7. Rizza RA, Mandarino LJ, Gerich JE. Dose–response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981;240:E630–E639
  8. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab. 1979;237:E214–E223
  9. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84:3666–3672
  10. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  11. National Cholesterol Education Program. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–2752
  13. Corbould A. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?. Diabetes Metab Res Rev. 2008;24:520–532
  14. Dunaif A, Green G, Futterweit W, Dobrjansky A. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1990;70:699–704
  15. Lasco A, Cucinotta D, Gigante A, Denuzzo G, Pedulla M, Trifiletti A, et al. No changes in peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide. Eur J Endocrinol. 1995;133:718–722
  16. Moghetti P, Tosi F, Castello R, Magnani CM, Negri C, Brun E, et al. The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab. 1996;81:952–960
  17. Cooper BC, Sites CK, Casson PR, Toth MJ. Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal. Fertil Steril. 2007;87:1131–1138
  18. Toth MJ, Cooper BC, Pratley RE, Mari A, Matthews DE, Casson PR. Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion. Am J Physiol Endocrinol Metab. 2008;294:E1035–E1045
  19. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SS. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab. 1992;75:577–583
  20. Dunaif A, Wu X, Lee A, Amanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab. 2001;281:E392–E399
  21. Adashi E. The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil Steril. 1994;62:20–27
  22. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90:3847–3853
  23. Attia GR, Rainey WE, Carr BR. Metformin directly inhibits androgen production in human thecal cells. Fertil Steril. 2001;76:517–524
  24. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health—National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab. 2008;93:1276–1284
  25. Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. 2003;108:1688–1693
  26. Wild RA, Grubb B, Hartz A, Van Nort JJ, Bachman W, Bartholomew M. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril. 1990;54:255–259
  27. Phillips GB, Pinkernell BH, Jing TY. Relationship between serum sex hormones and coronary artery disease in postmenopausal women. Arterioscler Thromb Vasc Biol. 1997;17:695–701
  28. Braunstein GD, Johnson BD, Stanczyk FZ, Bittner V, Berga SL, Shaw L, et al. Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. J Clin Endocrinol Metab. 2008;93:4268–4275
  29. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, et al. Insulin sensitivity and atherosclerosis. Circulation. 1996;93:1809–1817
  30. Bonora E, Tessari R, Micciolo R, Zenere M, Targher G, Padovani R, et al. Intimal–medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance. Diabetes Care. 1997;20:627–631
  31. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab. 1998;83:2773–2776

 S.M.P. has nothing to disclose. N.I. has nothing to disclose. S.K. has nothing to disclose. S.J.R. has nothing to disclose. M.R.R. has nothing to disclose. M.P.R. has nothing to disclose. T.S. has nothing to disclose. A.B. has nothing to disclose. C.F. has nothing to disclose. A.R.C. has nothing to disclose.

 Supported by K23 AG19161 from the National Institute on Aging, UL1RR024134 from the National Center for Research Resources, P30 DK19525 from the National Institute of Diabetes and Digestive and Kidney Diseases, the John A. Hartford Foundation, and the University of Pennsylvania Institute for Diabetes, Obesity, and Metabolism. The views expressed are those of the authors and do not necessarily represent the official views of the National Institutes of Health.

PII: S0015-0282(10)00139-1

doi: 10.1016/j.fertnstert.2010.01.064

Fertility and Sterility
Volume 94, Issue 6 , Pages 2161-2166 , November 2010

Article Tools

* Image Usage & Resolution